1. Home
  2. CPRX vs CXW Comparison

CPRX vs CXW Comparison

Compare CPRX & CXW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPRX
  • CXW
  • Stock Information
  • Founded
  • CPRX 2002
  • CXW 1983
  • Country
  • CPRX United States
  • CXW United States
  • Employees
  • CPRX N/A
  • CXW N/A
  • Industry
  • CPRX Biotechnology: Pharmaceutical Preparations
  • CXW Real Estate Investment Trusts
  • Sector
  • CPRX Health Care
  • CXW Real Estate
  • Exchange
  • CPRX Nasdaq
  • CXW Nasdaq
  • Market Cap
  • CPRX 2.6B
  • CXW 2.4B
  • IPO Year
  • CPRX 2006
  • CXW 1997
  • Fundamental
  • Price
  • CPRX $20.59
  • CXW $20.21
  • Analyst Decision
  • CPRX Strong Buy
  • CXW Strong Buy
  • Analyst Count
  • CPRX 5
  • CXW 3
  • Target Price
  • CPRX $33.20
  • CXW $33.33
  • AVG Volume (30 Days)
  • CPRX 1.5M
  • CXW 1.1M
  • Earning Date
  • CPRX 08-06-2025
  • CXW 08-06-2025
  • Dividend Yield
  • CPRX N/A
  • CXW N/A
  • EPS Growth
  • CPRX 183.96
  • CXW 57.89
  • EPS
  • CPRX 1.65
  • CXW 0.95
  • Revenue
  • CPRX $558,499,000.00
  • CXW $1,997,643,000.00
  • Revenue This Year
  • CPRX $16.51
  • CXW $9.30
  • Revenue Next Year
  • CPRX $9.58
  • CXW $11.85
  • P/E Ratio
  • CPRX $12.45
  • CXW $21.38
  • Revenue Growth
  • CPRX 28.55
  • CXW 1.62
  • 52 Week Low
  • CPRX $19.00
  • CXW $12.13
  • 52 Week High
  • CPRX $26.58
  • CXW $24.99
  • Technical
  • Relative Strength Index (RSI)
  • CPRX 48.79
  • CXW 44.13
  • Support Level
  • CPRX $19.83
  • CXW $20.26
  • Resistance Level
  • CPRX $21.82
  • CXW $20.69
  • Average True Range (ATR)
  • CPRX 0.57
  • CXW 0.51
  • MACD
  • CPRX 0.07
  • CXW -0.02
  • Stochastic Oscillator
  • CPRX 45.33
  • CXW 14.96

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).

About CXW CoreCivic Inc.

CoreCivic Inc is an owner and operator of private prisons and detention centers in the United States. It operates in three segments: Safety, Community, and Properties. The Community segment owns and operates residential reentry centers. The Properties segment owns properties for lease to third parties and government agencies. The vast majority of the company's revenue comes from the CoreCivic Safety segment which consists of correctional and detention facilities that are owned, or controlled via a long-term lease, and managed by the company, as well as those correctional and detention facilities owned by third parties but managed by CoreCivic.

Share on Social Networks: